Published: 2020-10-21

Serum uric acid levels in essential hypertension and its correlation with the severity of hypertension

Waseem Ramzan Dar, Sunil Kumar Gupta, Afzal Ahmad


Background: Serum uric acid has been closely linked and considered as an independent risk factor for development of hypertension. This study was carried out to assess the serum uric acid levels in essential hypertension and its correlation with the severity and known duration of hypertension.

Methods: The present observational case control study was conducted between November 2019 to February 2020 on total 100 out patients (30-65 years) of which 50 known cases of essential hypertension irrespective of treatment status and were graded into different stages of hypertension as per Joint National Committee VII (JNC VII) guidelines. Rest 50 patients who were age- sex matched and without any co-morbidity were included as control. Relevant clinical and laboratory data were recorded using proforma. Statistical analysis was done using Statistical package for social software (SPSS) software.

Results: Mean systolic/diastolic blood pressure (BP) was found significantly higher in cases 168/102 mmHg compare to control 114/74 mmHg. Among cases maximum patients were found in stage 2 hypertension which has significant difference in mean systolic/diastolic BP (186/112 mmHg, p<0.001) compare with stage 1 (146/94 mmHg) and isolated hypertensive patients (148/85 mmHg). Serum uric acid levels were significantly higher in stage 2 than other two hypertensive stages among cases and also compare to controls. Patients with >5 years of hypertension also has significant high serum uric acid level than <5 years of hypertension.

Conclusions: Serum uric acid can be used probably as an early biochemical marker to determine the severity of hypertension as stage 2 hypertensive had more elevation in serum uric acid levels as compared to other hypertensive patients.


Hypertension, Hyperuricemia, JNC VII, Uric acid

Full Text:



Feig DI, Johnson RJ. Hyperuricemia in childhood primary hypertension. Hypertension. 2003;42:247-52.

Vasan RS, Beiser A, Sheshadri S, Larson MG, Kannel WB, D'Agostino RB. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002;287:1003-10.

Haque T, Rahman S, Islam S, Molla NH, Ali N. Assessment of the relationship between serum uric acid and glucose levels in healthy, prediabetic and diabetic individuals. Diabetol Metab Syndr. 2019;11(49):1-8.

Kaplan NM. Systemic Hypertension: Mechanism and Diagnosis. In: Braunwald’s textbook of Cardiovascular Medicine 9th edition. Elsevier Saunders. 37:935-72.

Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL et al. Elevated uric acid increases blood pressure in the rat by a novel crystal independent mechanism. Hypertension. 2001;38:1101-6.

Zhou X, Matavelli L, Frohlich ED. Uric acid: its relationship to renal hemodynamics and the renal renin-angiotensin system. Curr Hypertens Rep. 2006;8:120-4.

Babinska K, Kovacs L, Janko V, Dallos T, Feber J. Association between obesity and the severity of ambulatory hypertension in children and adolescents. J Am Soc Hyperten. 2012;6:356-63.

Higashi Y, Kihara Y, Noma K. Endothelial dysfunction and hypertension in aging. Hypertens Res. 2012;35:1039-47.

Chobanian AV, Bakris GL, Black HR. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-52.

Reddy RP, Monigari N, Hande M. Study of Serum Uric Acid in Essential Hypertension. International J Sci Res Pub. 2015;5(8):1-12.

Poudel B, Yadav BK, Kumar A, Jha B, Raut KB. Serum uric acid level in newly diagnosed essential hypertension in a Nepalese population: A hospital based cross sectional study. Asian Pacif J Trop Biomed. 2014,4(1):59-64.

Eisen A, Benderly M, Goldbourt U, Haim M. Is serum uric acid level an independent predictor of heart failure among patients with coronary artery disease? Clin Cardiol. 2013;36:110-6.

Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2011;63:102-10.

Al- Sharifi ZAR, Al-Gebouri HG. Uric Acid and Endothelial Dysfunction in Essential Hypertension. Karbala J Med. 2010;4(3):914-8.

Vishnu RS, Dash LK, Murmu M. Observation of Serum Uric Acid levels in essential hypertension. Kerala Med J. 2013;6(3):65-70.

Vakil A, Vrkariya P, Barafiwala V, Gamit K, Patel D, Nilesh D. Study of Serum Uric Acid Level in Hypertension. J Den Med Sci. 2017;16(4):69-73.

Tykarski A. Evaluation of renal handling of uric acid in essential hypertension; hyperuricemia related to decreased urate secretion. Nephrol. 1991;59(3):364-8.

Neki NS, Tamilmani. A Study of Serum Uric Acid level in Essential Hypertension. JIMSA. 2015;28(1):13.

Messerli FH, Frohlich ED, Dreslinski GR. Serum Uric Acid in Essential Hypertension: an indicator of renal vascular involvement. Ann Intern Med. 1980;93:817-21.

Assadi F. Allopurinol enhances the blood pressure lowering effect of enalapril in children with hyperuricemic essential hypertension. J Nephrol. 2014;27:51-6.

Shibagaki Y, Ohno I, Hosoya T, Kimura K. Safety, efficacy and renal effect of febuxostat in patients with moderate-to-severe kidney dysfunction. Hypertens Res. 2014;37:919-25.